What is an earnout deal structure? How it works in M&A

An earnout deal structure defers part of the purchase price and ties it to the target’s post-close performance, rather than paying it all at closing. SRS Acquiom’s 2026 M&A Deal Terms Study found earnouts in 24% of private-target deals in 2025, up from 22% in 2024, and earnout disputes remain a common trigger of post-close M&A litigation.

Buyers and sellers often disagree on valuation when growth projections are aggressive or future revenue is uncertain. Earnouts in M&A let both sides say yes without settling that disagreement up front.

This guide covers how M&A earnout structures work, which metrics and periods are standard, how to protect yourself as a buyer or seller, and when contingent consideration makes sense.

How an earnout fits into the purchase price

An earnout is a deferred, performance-contingent portion of the purchase price that the buyer pays only if the acquired business hits agreed targets after closing. Put simply, that’s the earnout definition every deal team should work from. Instead of paying 100% at closing, the buyer holds back part of the consideration and releases it later, contingent on performance.

Total seller consideration breaks down into cash at closing, earnout payments if targets are met, and any other deferred value, such as a seller note or rollover equity. A buyer might pay $80 million upfront and up to an additional $20 million if EBITDA exceeds $5 million in year two post-close.

To define earnout precisely, it helps to see what it isn’t:

• A seller note is deferred but not performance-contingent – paid on a fixed schedule regardless of performance.
• Rollover equity ties the seller’s return to the company’s overall value, not to a metric.
• An earnout is not a purchase price adjustment: that mechanism true-ups the price for working capital, cash, debt, or other closing-date items.

Earnout size varies by sector, deal risk, and the valuation gap M&A teams are bridging. In life sciences, where earnouts bridge milestone-based value, Harvard Law School Forum cites median earnout payments of about 61% of total consideration.

How common are earnouts, and how long do they last?

Earnouts are far more common in private-target deals; public-company transactions more often use contingent value rights (CVRs) instead. SRS Acquiom’s 2026 Deal Terms Study found earnouts in 24% of private-target acquisitions that closed in 2025, up from 22% in 2024 and above the historical rate of roughly 15-20%. Public-target deals include earnouts in only about 1%, since public shareholders generally want certainty of value.

Sector matters more than deal size. Private pharmaceutical transactions used earnouts in more than 80% of deals in recent years, per Harvard Law School Forum, since a biotech or device company’s value often hinges on binary, verifiable events like FDA approval. Outside life sciences, the same analysis shows use rising from 15% in 2019 to 30-37% in 2023, before settling to roughly 22–24% in 2024-2025.

Duration follows a similar split: the median earnout period outside life sciences is 24 months, mostly 1–2 years. Life sciences earnouts run considerably longer – often three to five years – since regulatory and clinical timelines rarely resolve within two.

Why buyers and sellers agree to earnouts

For the buyer, an earnout reduces upfront capital risk when the seller projects growth the buyer can’t fully underwrite at signing, and it helps bridge information asymmetry with private targets.

For the seller, an earnout can capture upside if the business outperforms, and payments may defer some tax timing depending on structure. Most practically, it lets deals close where a straightforward price disagreement would otherwise kill the transaction.

The trade-off is asymmetric once the deal closes: the earnout shifts post-close risk onto the seller, because the buyer controls the business and the accounting decisions that determine whether the target is met.

Key components of an earnout deal structure

Every earnout agreement has to define five structural elements before signing. Under-specifying any one of them is a common root cause of post-close disputes.

• Earnout amount. Typically 10-25% of total consideration for mid-market deals. SRS Acquiom’s 2026 data puts the median earnout potential at 34% of the closing payment, up from 31% in 2024.
• Earnout period. Typically one to three years, with a 24-month median outside life sciences. Longer periods give the buyer more confidence but extend the seller’s exposure to factors outside their control.
• Performance metric. The most negotiated element, covered in depth below. Revenue, EBITDA, and non-financial milestones each carry different incentive and manipulation risks.
• Measurement rules. Define how the metric is calculated, who prepares it, and how disputes are resolved – an independent accounting firm or formal arbitration are both common.
• Protective covenants. Seller-side provisions restricting the buyer from actions that would artificially suppress the metric. The 2025 ABA Deal Points Study found only 14% of earnout deals require the buyer to run the business consistent with past practice, and just 5% require it to operate so as to maximize the earnout.

Revenue vs. EBITDA vs. milestone earnouts

Revenue earnouts are less affected by cost allocation but can reward low-margin growth: a seller motivated purely by hitting a revenue number can discount aggressively without improving profitability.

EBITDA earnouts align more closely with value creation, but are easier for the buyer to manipulate post-close through overhead allocation or accounting-policy changes – which is why sellers push for the protective covenants above.

Non-financial milestones – FDA approval, a product launch, a patent grant, a customer-retention threshold – are common in pharma, biotech, and SaaS deals. They’re harder to negotiate up front, but once defined, they’re more objective and less prone to manipulation.

Revenue remains the most common single metric: SRS Acquiom data shows it’s used in about 62% of deals with earnouts, versus about 22% for EBITDA or earnings. EBITDA frequently serves as the negotiated compromise, capturing more of the cost side than revenue while remaining less subjective than net income.

How sellers can negotiate stronger earnout protections

Once the deal closes, the buyer controls the business and the accounting and operational decisions that determine whether the earnout metric is met. Sellers have to protect their position contractually before signing.

Four protections are worth negotiating hard for:

• A revenue-based metric instead of EBITDA, where it fits the business model, and the buyer will accept it.
• A covenant against the buyer changing accounting policies or allocating new overhead without the seller’s consent.
• A neutral independent accounting firm to review disputed calculations.
• A defined dispute-resolution process – expert determination or arbitration – rather than open-ended litigation.

Sellers who accept vague language in the letter of intent struggle to tighten it later. Nail down metric definitions and dispute mechanics as early as the LOI stage, not after signing.

• Read more: Explore our guide to M&A deal structure to see how earnouts fit alongside asset purchases, stock purchases, mergers, and other structures.

Earnout accounting and tax considerations

Contingent consideration is the accounting term for the earnout obligation: additional consideration the buyer may owe if agreed post-close targets are met. Under ASC 805, recognize it at acquisition-date fair value and classify it as a liability, equity, or, less commonly, an asset. If classified as a liability or asset, subsequent fair-value changes generally hit earnings; if equity, the arrangement isn’t remeasured.

Earnout tax treatment depends on transaction structure and applicable law, and should be confirmed with tax advisors – this is not tax advice. In most US transactions, payments are taxed when received, which spreads the seller’s tax liability over the earnout period. If a buyer structures the earnout as employment compensation rather than purchase-price consideration, the seller may be taxed at ordinary income rates instead of capital gains rates – a critical distinction to confirm with an M&A tax advisor.

How a VDR supports earnout due diligence and post-close reviews

Negotiating an earnout deal structure requires the buyer to test the exact financial metrics that will determine payout, historical revenue quality, normalized EBITDA, and customer retention data, all organized in the data room.

That need doesn’t end at closing. Purchase agreements often grant sellers information or audit rights to verify earnout calculations during the performance period, and a virtual data room supports that with: 

• Structured Q&A workflows that keep buyer and seller questions, answers, and supporting documents in one tracked workspace.
• Audit trails that record who accessed each file, when, and what actions they took.
• Role-based permissions that control which financial, customer, and operating documents each party can access at each stage.

Ideals VDR supports due diligence on both sides of the transaction: helping buyers test the numbers behind the earnout metric during negotiation, and giving both parties a controlled, auditable workspace for earnout calculations and follow-up questions after closing.

• Read more: See our financial due diligence 101 guide to learn how buyers verify revenue quality, normalize EBITDA, and test financial assumptions.

Common earnout disputes and how to prevent them

Earnout disputes are a common source of post-close M&A litigation, and the root cause is usually ambiguity – in how the metric is defined, or in what the buyer may do with the business during the earnout period.

Three dispute triggers show up repeatedly:

• The buyer loads new costs onto the acquired business – overhead, allocations, integration expenses – that suppress the EBITDA the earnout depends on.
• The buyer changes accounting policies or methodologies mid-period, altering how the metric is calculated versus what the parties expected at signing.
• The buyer fails to operate the business in a way that gives the earnout a reasonable chance of success – cutting headcount, discontinuing a product line, or redirecting resources.

The strongest protections clearly define accounting consistency and dispute-resolution procedures up front. Sellers sometimes fall back on the implied covenant of good faith when the contract is silent, but Delaware courts apply it narrowly – as shown in J&J v. Fortis Advisors, where the Delaware Supreme Court reversed part of the earlier $1B+ damages award in January 2026. Explicit contractual earnout provisions remain the more reliable route.

Conclusion

An earnout deal structure is one of the most effective ways to bridge the valuation gap M&A teams face, but it works only when teams define the metric, measurement rules, and seller protections before signing. Vague calculations or broad buyer discretion are what turn a fair structure into a dispute.

The earnout period, performance metric, and protective covenants are the three levers every deal team needs to lock down before signing. Just as important is the infrastructure behind them – a data room built for structured Q&A, audit trails, and granular access control gives both buyer and seller a shared, auditable record from negotiation through the final earnout payment.

FAQ